Conducting Clinical Trials [electronic resource] /

A few years ago, two of us joined our senior colleague at Pharma­ Kinetics Laboratories, a newly public contract research firm just under­ taking a major expansion into the clinical trials market. The company's unique concept of clinical research held great promise and had suc­ cessfully endured many of the fits and starts characteristic of entrepre­ neurial organizations. With a staff of highly enthusiastic, albeit inex­ perienced, field personnel located in 30-odd cities around the country, we found ourselves off and running with several critical research pro­ grams for major pharmaceutical manufacturers. Our excitement with the innovation was tempered with the reality of staffing and bearing responsibility for more than 30 field offices and 300 new staff persons, more than half of whom had no previous experience in the pharma­ ceutical industry. In the ensuing few years, we explored by trial and error many workable and unworkable patterns of training! delegation, data collec­ tion, and auditing. The ideas expressed in this book benefited greatly from that experience and from the willingness of our co-workers and clients to share insights and problems. During those years, we also sought guidance from the works available on the clinical trials field. Although we found numerous references on research ethics, little guid­ ance was available on the practical aspects of conducting a clinical trial.

Saved in:
Bibliographic Details
Main Authors: Iber, Frank L. author., Riley, W. Anthony. author., Murray, Patricia J. author., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Boston, MA : Springer US, 1987
Subjects:Medicine., Pharmacology., Biomedicine., Pharmacology/Toxicology., Medicine/Public Health, general.,
Online Access:http://dx.doi.org/10.1007/978-1-4613-1919-1
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:190797
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine/Public Health, general.
Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine/Public Health, general.
spellingShingle Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine/Public Health, general.
Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine/Public Health, general.
Iber, Frank L. author.
Riley, W. Anthony. author.
Murray, Patricia J. author.
SpringerLink (Online service)
Conducting Clinical Trials [electronic resource] /
description A few years ago, two of us joined our senior colleague at Pharma­ Kinetics Laboratories, a newly public contract research firm just under­ taking a major expansion into the clinical trials market. The company's unique concept of clinical research held great promise and had suc­ cessfully endured many of the fits and starts characteristic of entrepre­ neurial organizations. With a staff of highly enthusiastic, albeit inex­ perienced, field personnel located in 30-odd cities around the country, we found ourselves off and running with several critical research pro­ grams for major pharmaceutical manufacturers. Our excitement with the innovation was tempered with the reality of staffing and bearing responsibility for more than 30 field offices and 300 new staff persons, more than half of whom had no previous experience in the pharma­ ceutical industry. In the ensuing few years, we explored by trial and error many workable and unworkable patterns of training! delegation, data collec­ tion, and auditing. The ideas expressed in this book benefited greatly from that experience and from the willingness of our co-workers and clients to share insights and problems. During those years, we also sought guidance from the works available on the clinical trials field. Although we found numerous references on research ethics, little guid­ ance was available on the practical aspects of conducting a clinical trial.
format Texto
topic_facet Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine/Public Health, general.
author Iber, Frank L. author.
Riley, W. Anthony. author.
Murray, Patricia J. author.
SpringerLink (Online service)
author_facet Iber, Frank L. author.
Riley, W. Anthony. author.
Murray, Patricia J. author.
SpringerLink (Online service)
author_sort Iber, Frank L. author.
title Conducting Clinical Trials [electronic resource] /
title_short Conducting Clinical Trials [electronic resource] /
title_full Conducting Clinical Trials [electronic resource] /
title_fullStr Conducting Clinical Trials [electronic resource] /
title_full_unstemmed Conducting Clinical Trials [electronic resource] /
title_sort conducting clinical trials [electronic resource] /
publisher Boston, MA : Springer US,
publishDate 1987
url http://dx.doi.org/10.1007/978-1-4613-1919-1
work_keys_str_mv AT iberfranklauthor conductingclinicaltrialselectronicresource
AT rileywanthonyauthor conductingclinicaltrialselectronicresource
AT murraypatriciajauthor conductingclinicaltrialselectronicresource
AT springerlinkonlineservice conductingclinicaltrialselectronicresource
_version_ 1756266106736082944
spelling KOHA-OAI-TEST:1907972018-07-30T23:15:08ZConducting Clinical Trials [electronic resource] / Iber, Frank L. author. Riley, W. Anthony. author. Murray, Patricia J. author. SpringerLink (Online service) textBoston, MA : Springer US,1987.engA few years ago, two of us joined our senior colleague at Pharma­ Kinetics Laboratories, a newly public contract research firm just under­ taking a major expansion into the clinical trials market. The company's unique concept of clinical research held great promise and had suc­ cessfully endured many of the fits and starts characteristic of entrepre­ neurial organizations. With a staff of highly enthusiastic, albeit inex­ perienced, field personnel located in 30-odd cities around the country, we found ourselves off and running with several critical research pro­ grams for major pharmaceutical manufacturers. Our excitement with the innovation was tempered with the reality of staffing and bearing responsibility for more than 30 field offices and 300 new staff persons, more than half of whom had no previous experience in the pharma­ ceutical industry. In the ensuing few years, we explored by trial and error many workable and unworkable patterns of training! delegation, data collec­ tion, and auditing. The ideas expressed in this book benefited greatly from that experience and from the willingness of our co-workers and clients to share insights and problems. During those years, we also sought guidance from the works available on the clinical trials field. Although we found numerous references on research ethics, little guid­ ance was available on the practical aspects of conducting a clinical trial.I. Introduction -- 1. Introduction -- II. Entering the Field of Clinical Trials -- 2. Deciding to Enter the Research Field -- 3. Physicians -- 4. Evaluating a Sponsor -- 5. Budget Planning and Development -- 6. Staff Selection and Training -- 7. Other Preparatory Activities -- III. The Institutional Review Mechanism -- 8. The Institutional Review Board Process -- IV. The Recruitment Process -- 9. Recruitment -- V. Critical Decision Points in a Clinical Trial -- 10. Informed Consent: Decision amid Uncertainty -- 11. Special Populations -- 12. The Enrollment/Continuation Decision -- 13. Compliance of Patients Currently on Study -- 14. Adverse On-Therapy Experiences -- 15. The Referral Process -- VI. Data Management -- 16. Principles of Data Management -- 17. Scheduling and Log Systems -- 18. The Research Chart -- 19. Study Checklists -- 20. The Case Report Form -- 21. Records of Excluded Patients -- 22. Regulatory Document Files -- 23. Record Storage and Access -- 24. Computer Technology in Data Management -- VII. Drug Accountability -- 25. Drug Accountability -- VIII. Enhancing Credibility -- 26. Publications and Presentations -- 27. Preventing Fraud -- 28. Quality Assurance -- 29. FDA Inspections -- IX. Appendixes -- A. Glossary -- B. Adverse Reaction Report -- C. Statement of Investigator -- D. General Reading.A few years ago, two of us joined our senior colleague at Pharma­ Kinetics Laboratories, a newly public contract research firm just under­ taking a major expansion into the clinical trials market. The company's unique concept of clinical research held great promise and had suc­ cessfully endured many of the fits and starts characteristic of entrepre­ neurial organizations. With a staff of highly enthusiastic, albeit inex­ perienced, field personnel located in 30-odd cities around the country, we found ourselves off and running with several critical research pro­ grams for major pharmaceutical manufacturers. Our excitement with the innovation was tempered with the reality of staffing and bearing responsibility for more than 30 field offices and 300 new staff persons, more than half of whom had no previous experience in the pharma­ ceutical industry. In the ensuing few years, we explored by trial and error many workable and unworkable patterns of training! delegation, data collec­ tion, and auditing. The ideas expressed in this book benefited greatly from that experience and from the willingness of our co-workers and clients to share insights and problems. During those years, we also sought guidance from the works available on the clinical trials field. Although we found numerous references on research ethics, little guid­ ance was available on the practical aspects of conducting a clinical trial.Medicine.Pharmacology.Biomedicine.Pharmacology/Toxicology.Medicine/Public Health, general.Springer eBookshttp://dx.doi.org/10.1007/978-1-4613-1919-1URN:ISBN:9781461319191